亞鉀國際(000893.SZ)半年度淨利潤預增4534%-6369%
格隆匯7月14日丨亞鉀國際(000893.SZ)公佈,預計2021年半年度歸屬於上市公司股東的淨利潤4.8億元-6.7億元,同比增長4534%-6369%。業績變動原因如下:
1、報吿期內,公司鉀肥業務營業收入同比上升,主要原因為公司圍繞經營發展戰略的調整,聚焦鉀肥核心業務,不斷加大銷售力度,鉀肥產品銷售業績較上年同期提升所致。
2、報吿期內,公司已剝離貿易及船運業務,不再對公司歸屬於上市公司股東的淨利潤產生負面影響。
3、報吿期內,預計非經常性損益金額為4.44億元至6.46億元,主要原因為公司通過法律手段積極維護廣大投資者利益,逐步化解公司歷史遺留問題,訴訟案件相應的補償款增加公司當期利潤所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.